Delivery Order SPE2DB20D7059-SPE2DB25FQJD3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,996.70 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a commonly prescribed antiemetic medication used to prevent nausea and vomiting, particularly in medical and...
- The Defense Logistics Agency awarded a delivery order valued at $4,566.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 8 mg in quantities of 30 tablets. The contract is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with completion expected by July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $5,137.00 under a firm fixed-price contract. This non-set-aside award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly prescribed to prevent nausea and...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Ondansetron is a widely used anti-nausea medication commonly...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,854.40 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron ODT 8mg in a quantity of 30 units. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea and...
- The Defense Logistics Agency awarded a delivery order valued at $1,437.70 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025. The award was made through open competition without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $35,959.67 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly prescribed to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) valued at $2,863.37. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used anti-nausea medication utilized across military healthcare systems to manage post-operative and...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQJD3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,859.46 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price contract was competitively awarded on June 7, 2025, with an ultimate completion date of June 9, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. Ondansetron is a commonly prescribed antiemetic medication used to prevent nausea and vomiting, particularly in military and veteran healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide through the DLA Medical Supply Chain. The company's role as a prime vendor underscores its established capability to fulfill federal medical supply requirements across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 6/7/25 |